2020
DOI: 10.4103/1319-2442.279963
|View full text |Cite
|
Sign up to set email alerts
|

Aldosterone renin ratio and chronic kidney disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 47 publications
0
3
0
Order By: Relevance
“…In view of a high prevalence of non-communicable disease and high early CKD population, there is an important need to consider comprehensive management strategies that involve the blockage of high renin-angiotensin-aldosterone and the use of mineral corticosteroid receptor blockers [27]. A study by Bomback et al found a shift of the volume-aldosterone curve in the HD population suggesting that ESKD is a state of high volume and inappropriately high aldosterone [28].…”
Section: Discussionmentioning
confidence: 99%
“…In view of a high prevalence of non-communicable disease and high early CKD population, there is an important need to consider comprehensive management strategies that involve the blockage of high renin-angiotensin-aldosterone and the use of mineral corticosteroid receptor blockers [27]. A study by Bomback et al found a shift of the volume-aldosterone curve in the HD population suggesting that ESKD is a state of high volume and inappropriately high aldosterone [28].…”
Section: Discussionmentioning
confidence: 99%
“…Previously, BPS was primarily used for peripheral arterial occlusive disease and pulmonary arterial hypertension [ 5 , 6 ]. Some studies have shown that BPS delays the progression of CKD [ 7 ]. BPS functions in CKD by improving renal microcirculation disturbances, reducing the generation of inflammatory factors, protecting vascular endothelial cells, and preventing interstitial fibrosis development [ 7 , 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…Some studies have shown that BPS delays the progression of CKD [ 7 ]. BPS functions in CKD by improving renal microcirculation disturbances, reducing the generation of inflammatory factors, protecting vascular endothelial cells, and preventing interstitial fibrosis development [ 7 , 8 ]. Based on these mechanisms, BPS has renoprotective and anti-inflammatory effects.…”
Section: Introductionmentioning
confidence: 99%